{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:47:14Z","timestamp":1746337634333},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2010,8,12]],"date-time":"2010-08-12T00:00:00Z","timestamp":1281571200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1038\/hr.2010.145","type":"journal-article","created":{"date-parts":[[2010,8,12]],"date-time":"2010-08-12T06:04:13Z","timestamp":1281593053000},"page":"1150-1154","source":"Crossref","is-referenced-by-count":9,"title":["Strong suppression of the renin\u2013angiotensin system has a renal-protective effect in hypertensive patients: High-dose ARB with ACE inhibitor (Hawaii) study"],"prefix":"10.1038","volume":"33","author":[{"given":"Mitsuru","family":"Ohishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Takeya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Tatara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyuki","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Maekawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Kamide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Rakugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,8,12]]},"reference":[{"key":"BFhr2010145_CR1","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/01.mnh.0000232875.27846.7e","volume":"15","author":"CA Peralta","year":"2006","unstructured":"Peralta CA, Kurella M, Lo JC, Chertow GM . The metabolic syndrome and chronic kidney disease. Curr Opin Nephrol Hypertens 2006; 15: 361\u2013365.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"BFhr2010145_CR2","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1097\/01.ASN.0000127045.14709.75","volume":"15","author":"J Segura","year":"2004","unstructured":"Segura J, Campo C, Gil P, Roldan C, Vigil L, Rodicio JL, Ruilope LM . Development of chronic kidney disease and cardiovascular prognosis in essential hypertensive patients. J Am Soc Nephrol 2004; 15: 1616\u20131622.","journal-title":"J Am Soc Nephrol"},{"key":"BFhr2010145_CR3","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1097\/01.ASN.0000027871.86296.92","volume":"13","author":"PW De Leeuw","year":"2002","unstructured":"De Leeuw PW, Thijs L, Birkenhager WH, Voyaki SM, Efstratopoulos AD, Fagard RH, Leonetti G, Nachev C, Petrie JC, Rodicio JL, Rosenfeld JJ, Sarti C, Staessen JA . Prognostic significance of renal function in elderly patients with isolated systolic hypertension: results from the Syst-Eur trial. J Am Soc Nephrol 2002; 13: 2213\u20132222.","journal-title":"J Am Soc Nephrol"},{"key":"BFhr2010145_CR4","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1111\/j.1523-1755.2005.09910.x","volume":"58","author":"R Marin","year":"2005","unstructured":"Marin R, Gorostidi M, Fernandez-Vega F, Alvarez-Navascues R . Systemic and glomerular hypertension and progression of chronic renal disease: the dilemma of nephrosclerosis. Kidney Int 2005; 58: S52\u2013S56.","journal-title":"Kidney Int"},{"key":"BFhr2010145_CR5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1254\/jphs.FMJ05002X6","volume":"99","author":"K Hayashi","year":"2005","unstructured":"Hayashi K, Wakino S, Homma K, Sugano N, Saruta T . Pathophysiological significance of T-type Ca2+ channels: role of T-type Ca2+ channels in renal microcirculation. J Pharmacol Sci 2005; 99: 221\u2013227.","journal-title":"J Pharmacol Sci"},{"key":"BFhr2010145_CR6","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1291\/hypres.28.611","volume":"28","author":"T Wang","year":"2005","unstructured":"Wang T, Takabatake T . Effects of vasopeptidase inhibition on renal function and tubuloglomerular feedback in spontaneously hypertensive rats. Hypertens Res 2005; 28: 611\u2013618.","journal-title":"Hypertens Res"},{"key":"BFhr2010145_CR7","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1056\/NEJMoa011161","volume":"345","author":"BM Brenner","year":"2001","unstructured":"Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S . Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861\u2013869.","journal-title":"N Engl J Med"},{"key":"BFhr2010145_CR8","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(05)71082-5","volume":"365","author":"P Ruggenenti","year":"2005","unstructured":"Ruggenenti P, Perna A, Loriga G, Ganeva M, Ene-Iordache B, Turturro M, Lesti M, Perticucci E, Chakarski IN, Leonardis D, Garini G, Sessa A, Basile C, Alpa M, Scanziani R, Sorba G, Zoccali C, Remuzzi G . Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial. Lancet 2005; 365: 939\u2013946.","journal-title":"Lancet"},{"key":"BFhr2010145_CR9","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1056\/NEJMoa011489","volume":"345","author":"HH Parving","year":"2001","unstructured":"Parving HH, Lehnert H, Brochner-Mortensen J, Gomis R, Andersen S, Arner P . The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001; 345: 870\u2013878.","journal-title":"N Engl J Med"},{"key":"BFhr2010145_CR10","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1291\/hypres.30.1187","volume":"30","author":"M Ohishi","year":"2007","unstructured":"Ohishi M, Takagi T, Ito N, Tatara Y, Hayashi N, Shiota A, Iwamoto Y, Katsuya T, Rakugi H, Ogihara T . Renal protective effect in hypertensive patients: the high doses of angiotensin II receptor blocker (HARB) study. Hypertens Res 2007; 30: 1187\u20131192.","journal-title":"Hypertens Res"},{"key":"BFhr2010145_CR11","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1056\/NEJMoa010713","volume":"345","author":"JN Cohn","year":"2001","unstructured":"Cohn JN, Tognoni G . A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 2001; 345: 1667\u20131675.","journal-title":"N Engl J Med"},{"key":"BFhr2010145_CR12","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1056\/NEJMoa032292","volume":"349","author":"MA Pfeffer","year":"2003","unstructured":"Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Kober L, Maggioni AP, Solomon SD, Swedberg K, Van de Werf F, White H, Leimberger JD, Henis M, Edwards S, Zelenkofske S, Sellers MA, Califf RM, Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Kober L, Maggioni AP, Solomon SD, Swedberg K, Van de Werf F, White H, Leimberger JD, Henis M, Edwards S, Zelenkofske S, Sellers MA, Califf RM . Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 2003; 349: 1893\u20131906.","journal-title":"N Engl J Med"},{"key":"BFhr2010145_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1472-8206.2007.00464.x","volume":"21","author":"F Zannad","year":"2007","unstructured":"Zannad F, Fay R . Blood pressure-lowering efficacy of olmesartan relative to other angiotensin II receptor antagonists: an overview of randomized controlled studies. Fundam Clin Pharmacol 2007; 21: 181\u2013190.","journal-title":"Fundam Clin Pharmacol"},{"key":"BFhr2010145_CR14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10157-006-0453-4","volume":"11","author":"E Imai","year":"2007","unstructured":"Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Hara S, Ura N, Kiyohara Y, Hirakata H, Watanabe T, Moriyama T, Ando Y, Inaguma D, Narita I, Iso H, Wakai K, Yasuda Y, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S . Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol 2007; 11: 41\u201350.","journal-title":"Clin Exp Nephrol"},{"key":"BFhr2010145_CR15","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1097\/00004872-200306000-00001","volume":"21","author":"European Society of Hypertension-European Society of Cardiology Guidelines Committee","year":"2003","unstructured":"European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology Guidelines for the Management of Arterial Hypertension. J Hypertens 2003; 21: 1011\u20131053.","journal-title":"J Hypertens"},{"key":"BFhr2010145_CR16","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","volume":"289","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, Jones DW, Materson BJ, Oparil S, Wright Jr JT, Roccella EJ . The Seventh Report of the Joint National Committee On Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 Report. JAMA 2003; 289: 2560\u20132572.","journal-title":"JAMA"},{"key":"BFhr2010145_CR17","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","volume":"288","author":"ALLHAT Officers Coordinators for the ALLHAT Collaborative Research Group","year":"2002","unstructured":"ALLHAT Officers Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981\u20132997.","journal-title":"JAMA"},{"key":"BFhr2010145_CR18","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","volume":"363","author":"S Julius","year":"2004","unstructured":"Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, Hua T, Laragh J, McInnes GT, Mitchell L, Plat F, Schork A, Smith B, Zanchetti A . Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 2004; 363: 2022\u20132031.","journal-title":"Lancet"},{"key":"BFhr2010145_CR19","doi-asserted-by":"publisher","first-page":"754","DOI":"10.7326\/0003-4819-123-10-199511150-00003","volume":"123","author":"JC Peterson","year":"1995","unstructured":"Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, King AJ, Klahr S, Massry SG, Seifter JL . Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med 1995; 123: 754\u2013762.","journal-title":"Ann Intern Med"},{"issue":"suppl 1","key":"BFhr2010145_CR20","first-page":"S196","volume":"2","author":"M Weinberg","year":"2001","unstructured":"Weinberg M, Weinberg A, Cord R, Zappe D . The effect of high-dose angiotensin II receptor blockade beyond maximal recommended doses in reducing urinary protein excretion. JRAAS 2001; 2 (suppl 1): S196\u2013S198.","journal-title":"JRAAS"},{"key":"BFhr2010145_CR21","first-page":"II","volume":"114","author":"NK Hollenberg","year":"2006","unstructured":"Hollenberg NK, Parving HH, Viberti G, Remuzzi G . The Diovan reduction of proteinuiria (drop) study: albuminuria response to high-doses of valsartan in type 2 diabetes mellitus. Circulation 2006; 114: II\u201361.","journal-title":"Circulation"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/hr2010145.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr2010145","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr2010145.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:05:43Z","timestamp":1684429543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hr2010145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,12]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["BFhr2010145"],"URL":"https:\/\/doi.org\/10.1038\/hr.2010.145","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,12]]}}}